IV 
115TH CONGRESS 
2D SESSION 
H. RES. 1095 
Expressing support for the designation of September 2018 as National 
Ovarian Cancer Awareness Month. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 27, 2018 
Ms. DELAURO (for herself, Mr. DUFFY, Mrs. DINGELL, Ms. WASSERMAN 
SCHULTZ, Mrs. COMSTOCK, Mr. LARSON of Connecticut, Mr. VELA, Mrs. 
MIMI WALTERS of California, Ms. BASS, Mr. MEEKS, Ms. BORDALLO, 
Mrs. LAWRENCE, Ms. MENG, Ms. VELA´ZQUEZ, Mr. CARBAJAL, Mr. 
FITZPATRICK, Ms. MCCOLLUM, Mr. AL GREEN of Texas, Mrs. BUSTOS, 
Mr. COHEN, Ms. MOORE, Mr. CLEAVER, Mr. GRIJALVA, Mr. LIPINSKI, 
Mr. RASKIN, Mr. HASTINGS, Ms. CASTOR of Florida, and Mr. RENACCI) 
submitted the following resolution; which was referred to the Committee 
on Oversight and Government Reform 
RESOLUTION 
Expressing support for the designation of September 2018 
as National Ovarian Cancer Awareness Month. 
Whereas ovarian cancer is the deadliest of all gynecologic 
cancers; 
Whereas ovarian cancer is the fifth leading cause of cancer 
deaths among women in the United States; 
Whereas, in 2018, in the United States, approximately 
22,240 new cases of ovarian cancer will be diagnosed, 
and 14,070 women will die of ovarian cancer; 
VerDate Sep 11 2014 
00:54 Sep 28, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1095.IH
HR1095
lotter on DSKBCFDHB2PROD with BILLS
•HRES 1095 IH 
Whereas the mortality rate for ovarian cancer has not signifi-
cantly decreased since the ‘‘War on Cancer’’ was declared 
more than 40 years ago; 
Whereas 1⁄4 of women will die within 1 year of being diag-
nosed with ovarian cancer, and more than 1⁄2 will die 
within 5 years of that diagnosis; 
Whereas while the mammogram can detect breast cancer and 
the Pap smear can detect cervical cancer, there is no reli-
able early detection test for ovarian cancer; 
Whereas the lack of an early detection test means that ap-
proximately 80 percent of cases of ovarian cancer are de-
tected at an advanced stage; 
Whereas all women are at risk for ovarian cancer, but ap-
proximately 20 percent of women who are diagnosed with 
ovarian cancer have a hereditary predisposition to ovar-
ian cancer, which places them at even higher risk; 
Whereas scientists and physicians have uncovered changes in 
the BRCA genes that some women inherit from their 
parents, which may make those women 30 times more 
likely to develop ovarian cancer; 
Whereas the family history of a woman has been found to 
play an important role in accurately assessing the risk of 
that woman of developing ovarian cancer, and medical ex-
perts believe that family history should be taken into con-
sideration during the annual well-woman visit of any 
woman; 
Whereas many experts in health prevention now recommend 
genetic testing for young women with a family history of 
breast and ovarian cancer; 
Whereas women who know that they are at high risk of 
breast and ovarian cancer may undertake prophylactic 
VerDate Sep 11 2014 
00:54 Sep 28, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1095.IH
HR1095
lotter on DSKBCFDHB2PROD with BILLS
•HRES 1095 IH 
measures to help reduce the risk of developing those dis-
eases; 
Whereas the Society of Gynecologic Oncology recommends 
that all women who are diagnosed with ovarian cancer re-
ceive counseling and genetic testing; 
Whereas many people are unaware that the symptoms of 
ovarian cancer often include bloating, pelvic or abdominal 
pain, difficulty eating or feeling full quickly, urinary 
symptoms, and several other symptoms that are easily 
confused with other diseases; 
Whereas awareness of the symptoms of ovarian cancer by 
women and health care providers can lead to a quicker 
diagnosis; 
Whereas, in June 2007, the first national consensus state-
ment on ovarian cancer symptoms was developed to pro-
vide consistency in describing symptoms to make it easier 
for women to learn and remember those symptoms; and 
Whereas each year during the month of September, the Ovar-
ian Cancer Research Fund Alliance and community part-
ners hold a number of events to increase public aware-
ness of ovarian cancer: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of National Ovar-
ian Cancer Awareness Month; and 
(2) supports the goals and ideals of National 
Ovarian Cancer Awareness Month. 
Æ 
VerDate Sep 11 2014 
00:54 Sep 28, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR1095.IH
HR1095
lotter on DSKBCFDHB2PROD with BILLS